|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 |
| (11) | Number of the document | 2288382 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09742459.2 |
| Date of filing the European patent application | 2009-05-05 | |
| (97) | Date of publication of the European application | 2011-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2009/005796 |
| Date | 2009-05-05 |
| (87) | Number | WO 2009/136286 |
| Date | 2009-11-12 |
| (30) | Number | Date | Country code |
| 98369 P | 2008-09-19 | US | |
| 126465 P | 2008-05-05 | US |
| (72) |
MASTERNAK, Krzysztof, CH
LEGER, Olivier, FR
|
| (73) |
NovImmune SA,
14 ch. des Aulx 1228 Plan-Les-Ouates, Geneva,
CH
|
| (54) | ANTI- IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF |
| ANTI- IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF |